Experts share here what they take away from the Conference on Retroviruses and Opportunistic Infections (CROI) each year and why this meeting is so important in this space. The combination of ...

The Conference on Retroviruses and Opportunistic Infections 2025 (CROI) featured multiple sessions that focused on breaking research and treatments. The Conference on Retroviruses and ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

In 2020, the Conference on Retroviruses and Opportunistic Infections (CROI) was the first scientific conference to move from in-person to virtual due to the COVID-19 pandemic. On the fifth anniversary ...

Global progress against HIV is at risk as aid cuts could trigger millions of new infections and deaths, potentially setting ...

Researchers at UW are pioneering long-acting injectable HIV therapies that have the potential to simplify and expand ...

Data derived from Herbert C, et al. Abstract 935. Presented at: Conference on Retroviruses and Opportunistic Infections; March 9-12, 2025; San Francisco. According to Antar, studies in the last 2 ...

researchers said at the Conference on Retroviruses and Opportunistic Infections. SAN FRANCISCO — Researchers here described how they were able to safely and ethically enroll adolescents in a ...

A Save Our Sciences rally March 10 at the Yerba Buena Gardens in the city's South of Market neighborhood – adjacent to the Moscone Center, where the Conference on Retroviruses and Opportunistic ...

This study that evaluates an annual injection of a pre-exposure prophylaxis medication for HIV has been published in The Lancet and presented simultaneously at the Conference on Retroviruses and ...